Cardiex Ltd (CDX) - Total Liabilities
Based on the latest financial reports, Cardiex Ltd (CDX) has total liabilities worth AU$10.39 Million AUD (≈ $7.35 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Cardiex Ltd to assess how effectively this company generates cash.
Cardiex Ltd - Total Liabilities Trend (2002–2024)
This chart illustrates how Cardiex Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Cardiex Ltd (CDX) asset resilience to evaluate the company's liquid asset resilience ratio.
Cardiex Ltd Competitors by Total Liabilities
The table below lists competitors of Cardiex Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acumentis Group Ltd
AU:ACU
|
Australia | AU$12.24 Million |
|
Herkules S.A.
WAR:HRS
|
Poland | zł152.01 Million |
|
Aqua Metals Inc
NASDAQ:AQMS
|
USA | $4.94 Million |
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
Indonesia | Rp421.65 Billion |
|
EUDA Health Holdings Limited
NASDAQ:EUDA
|
USA | $5.85 Million |
|
Origin Agritech Ltd
NASDAQ:SEED
|
USA | $151.71 Million |
|
Speedvalue Ltd
TA:SPDV
|
Israel | ILA54.97 Million |
Liability Composition Analysis (2002–2024)
This chart breaks down Cardiex Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Cardiex Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cardiex Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cardiex Ltd (2002–2024)
The table below shows the annual total liabilities of Cardiex Ltd from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | AU$8.56 Million ≈ $6.06 Million |
-44.05% |
| 2023-06-30 | AU$15.30 Million ≈ $10.83 Million |
+165.38% |
| 2022-06-30 | AU$5.77 Million ≈ $4.08 Million |
+71.94% |
| 2021-06-30 | AU$3.35 Million ≈ $2.37 Million |
-30.06% |
| 2020-06-30 | AU$4.80 Million ≈ $3.39 Million |
-23.41% |
| 2019-06-30 | AU$6.26 Million ≈ $4.43 Million |
+244.45% |
| 2018-06-30 | AU$1.82 Million ≈ $1.29 Million |
+11.41% |
| 2017-06-30 | AU$1.63 Million ≈ $1.15 Million |
+11.54% |
| 2016-06-30 | AU$1.46 Million ≈ $1.03 Million |
-9.68% |
| 2015-06-30 | AU$1.62 Million ≈ $1.15 Million |
+20.21% |
| 2014-06-30 | AU$1.35 Million ≈ $953.32K |
-9.94% |
| 2013-06-30 | AU$1.50 Million ≈ $1.06 Million |
-34.88% |
| 2012-06-30 | AU$2.30 Million ≈ $1.63 Million |
+3.52% |
| 2011-06-30 | AU$2.22 Million ≈ $1.57 Million |
+2.53% |
| 2010-06-30 | AU$2.16 Million ≈ $1.53 Million |
-33.50% |
| 2009-06-30 | AU$3.26 Million ≈ $2.30 Million |
+63.62% |
| 2008-06-30 | AU$1.99 Million ≈ $1.41 Million |
-1.61% |
| 2007-06-30 | AU$2.02 Million ≈ $1.43 Million |
+40.51% |
| 2006-06-30 | AU$1.44 Million ≈ $1.02 Million |
-6.62% |
| 2005-06-30 | AU$1.54 Million ≈ $1.09 Million |
+82.80% |
| 2004-06-30 | AU$843.00K ≈ $596.48K |
+73.10% |
| 2003-06-30 | AU$487.00K ≈ $344.58K |
-36.42% |
| 2002-06-30 | AU$766.00K ≈ $541.99K |
-- |
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more